The prognosis of adult Still’s disease is not generalizable. The majority of patients have a good prognosis, while a small number of patients with continued progression of the disease may develop joint deformities, etc., which are related to whether the disease is treated early or not, and the organs and severity of the disease involved.
The course of adult Still’s disease is variable, with most patients having a favorable prognosis. The majority of patients have an effective remission without recurrence if treated within the first year of disease onset; a few patients may have a relapse after remission, but most of the relapses are less severe than the initial symptoms.
In a few patients, the disease shows continuous activity, and serious complications such as severe liver damage, macrophage activation syndrome, and joint deformities may occur, affecting the quality of life. Patients with damage to vital organs such as the heart, lungs, and liver at the onset of the disease may develop functional abnormalities of the organs, even leading to death.
Adult patients with STI are advised to go to the rheumatology and immunology department of regular hospitals as soon as possible for early and standardized treatment under the guidance of doctors.